Seres Therapeutics' IPO

Seres Therapeutics raised a round of funding on June 26, 2015. Investors include Public.

Seres Therapeutics is a clinical-stage therapeutics company developing novel products to treat a host of disease conditions based on novel scientific findings related to the human microbiome. The comp…

Articles about Seres Therapeutics' IPO: